SummitTX Capital L.P. Sells 41,696 Shares of The Clorox Company $CLX

SummitTX Capital L.P. trimmed its holdings in shares of The Clorox Company (NYSE:CLX) by 86.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,731 shares of the company’s stock after selling 41,696 shares during the quarter. SummitTX Capital L.P.’s holdings in Clorox were worth $698,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. State Street Corp boosted its stake in shares of Clorox by 3.5% during the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company’s stock worth $1,039,946,000 after acquiring an additional 282,794 shares in the last quarter. Invesco Ltd. increased its holdings in shares of Clorox by 22.1% during the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after acquiring an additional 884,751 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Clorox by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock valued at $318,613,000 after acquiring an additional 10,060 shares in the last quarter. Van ECK Associates Corp raised its stake in shares of Clorox by 15.7% in the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock valued at $316,244,000 after acquiring an additional 426,433 shares in the last quarter. Finally, Two Sigma Investments LP lifted its holdings in Clorox by 33.8% in the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after purchasing an additional 439,797 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Performance

Shares of NYSE CLX opened at $96.69 on Friday. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The business’s 50 day moving average is $95.49 and its two-hundred day moving average is $103.72. The company has a market cap of $11.69 billion, a P/E ratio of 15.70 and a beta of 0.54. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $128.90.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period in the previous year, the company earned $1.45 earnings per share. The company’s quarterly revenue was up .1% compared to the same quarter last year. On average, equities analysts expect that The Clorox Company will post 5.52 EPS for the current year.

Analysts Set New Price Targets

Several brokerages have commented on CLX. Citigroup lowered their price target on Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Morgan Stanley reduced their price objective on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research note on Friday, May 1st. JPMorgan Chase & Co. decreased their price objective on shares of Clorox from $95.00 to $92.00 and set an “underweight” rating for the company in a report on Thursday, July 16th. Royal Bank Of Canada lowered their target price on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. Finally, Wells Fargo & Company dropped their target price on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a report on Monday, May 18th. Twelve research analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce” and an average target price of $101.00.

Insider Transactions at Clorox

In related news, Director Pierre R. Breber bought 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The shares were acquired at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the transaction, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.63% of the company’s stock.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.